Latest News in Cancer
Stay updated with the most recent articles and resources.
Main Topics
Personalized T-Cell therapies in the treatment of hematological malignancies
CAR-T cell therapy is a novel immunotherapy where a patient's T-cells are engineered to identify and destroy cancer cells. This personalized medicine has produced tremendous...
Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment
CAR T cell therapy has transformed cancer treatment, especially in hematological malignancies. Treatment of solid tumors remains challenging due to their immunosuppressive tumor microenvironment. Combination...
How to prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies?
CAR T-cell therapy revolutionized cancer therapy, offering incredible success in the management of B-cell malignancies, but it is associated with severe infection risks secondary to...
Donor T cells for CAR T cell therapy
Donor-derived (allogeneic) CAR T cell therapy provides a scalable, affordable substitute for patient-specific (autologous) treatment, offering "off-the-shelf" therapy for cancer patients. Although difficulties such as...
Strategies to optimize chimeric antigen receptor T-cell therapy in hematologic malignancies: Experience from China
China has made significant strides in optimizing chimeric antigen receptor (CAR) T-cell therapy for hematologic malignancies. Key strategies include improving CAR design to enhance efficacy...
CAR T-cell therapies in China: A Journey of Rapid Growth and Promise
The field of cancer therapy has been transformed with the introduction of chimeric antigen receptor (CAR) T-cell therapies, particularly in the field of hematological malignancies....
Atezolizumab and hyaluronidase-tqjs is approved by FDA for subcutaneous injection
On September 12, 2024, the Food and Drug Administration sanctioned atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza, Genentech, Inc.) for subcutaneous administration for all adult indications corresponding...
Limkato: Korea’s first CAR T Cell therapy
South Korea is making significant strides in **CAR T cell therapy**, highlighted by the approval of **Limkato**, the first domestically developed CAR T therapy by...
TIL therapy for melanoma in China
Tumor-Infiltrating Lymphocyte (TIL) therapy represents a promising advancement in the treatment of melanoma, particularly in cases where traditional treatments have failed. In China, the adoption...
CAR T Cell therapy for breast cancer in China
Chimeric Antigen Receptor T-cell, or CAR T-cell therapy, has been a revolutionary form of treatment against numerous types of cancers such as breast cancer. In...
CAR T Cell therapy for pancreatic cancer in China
Pancreatic cancer is an aggressive cancer that is hard to detect until late in its course, and hence, treatment is challenging. It originates in the...
CAR T Cell Therapy for Glioblastoma in China: A Revolutionary Approach to Brain Tumor Treatment
GBM The glioblastoma multiforme (GBM) is considered the most aggressive and lethal type of brain tumor. Despite treatments that include surgery, radiation, and chemotherapy, it...
Need help? Our team is ready to assist you.
We wish a speedy recovery for your loved ones.